Webinars

In these online education webinars, leading experts address current treatments and controversies in various urological subspecialties.

Every month, international key opinion leaders explain the latest urological developments in a concise presentation and give ample opportunities to interact and pose questions. All webinars will be recorded and can be reviewed at a later stage. Both advanced urologists as urologists in training can enjoy the webinars for free via desktop, tablet or mobile phone, anytime, anywhere.

 

Upcoming webinars

Radical Cystectomy: the urologist nightmare!

Presenter:
Prof. J. Palou, Barcelona (ES)
Save the date: Tuesday, 29 September 2020
Time: 18:30 to 19:30 (Central European Time)

Radical cystectomy is the established surgery for MIBC and for patients who fail conservative treatment in NMIBC.

It is one of the most complex surgeries in urology and we have to be very careful in every step of the procedure: the excision of the bladder and nodes and the reconstruction of the urinary and intestinal tracts.

This is why there are so many complications, the majority being Clavien 2 or less, but around 10-20% of surgeries have Clavien 3 complications. It is not uncommon to have to deal with decisions related to an unexpected evolution during the in-hospital postoperative period or also when the patient is back home.

In this webinar I will present how to diagnose and manage the most common nightmares in cystectomized patients!

Participation is free!

Register here

 

BCG unresponsive disease how this definition impact your treatment decision making

Presenter:
Prof. S. Shariat, Vienna (AT)
Save the date: Tuesday, 13 October 2020
Time: 18:30 to 19:30 (Central European Time)

Take-home messages:

  • The definition of BCG unresponsive disease is critical in counseling and managing patients—this is defined as a high-grade tumor after at least 2 courses of BCG within 6 months of the last BCG dose
  • Radical cystectomy is the optimal cancer treatment option in this setting
  • Intravesical chemotherapy is an option if the patient is unwilling/unable to undergo a radical cystectomy and no trials are available at the treatment site
  • Clinical trials represent an option if the patient is unwilling/unable to undergo a radical cystectomy – targeted agents and checkpoint inhibitor trials are ongoing, and the interferon adenoviral trial has completed enrolling and we are awaiting data

Participation is free!

Register here

 

An update on fluorescence guided surgery

Presenter:
Dr. H.G. van der Poel, Amsterdam (NL)
Dr. F.W.B. van Leeuwen, Leiden (NL)
Save the date: Monday, 26 October 2020
Time: 18:30 to 19:30 (Central European Time)

Participation is free!

Register here

Recorded Webinars